ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

Zacks Investment Research News Agency

5 hours ago•Zacks Investment Research

Stocks Medium Importance Neutral

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.

Related Symbols 1

A ANGO ANGO

Source: Zacks Investment Research

Visit Source

0 0 0

Comment

Comments

No comments yet

Be the first person to comment on this news item.

Category Stocks

Source Zacks Investment Research

Published 5 hours ago

Likes 0

Comments 0

Shares 0

News ID #2,318

Status Published

This news may have been collected automatically from third-party sources. Please verify important information through the original source and other reliable sources before making any trading or investment decision. This content is provided for informational purposes only and does not constitute financial advice.

Keep comments relevant to the news topic and avoid offensive, promotional, spam, or misleading content.

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

Comments

User Menu